Men's Health Week offers an opportunity to highlight the importance of prostate health as a key component of men's overall health and well-being. Recent evidence has revealed an increasingly close relationship Between Benign Prostatic Hyperplasia (BPH), Lower Urinary Tract Symptoms…
Irritable Bowel Syndrome (IBS) is one of the most common gastrointestinal disorders, yet it remains widely misunderstood. Marked by recurring symptoms such as abdominal pain, bloating, and changes in bowel habits, IBS can significantly affect quality of life1. On World…
Theakine IBS-C: our Supplement Solution for IBS-C For years, Adamas Biotech has been engaged in the development of nutraceutical solutions for individual well-being. Over the last three years, we have focused our research and development activities on the needs of…
Adamas Biotech® announces that it has filed a patent application with the Italian Patent and Trademark Office for an innovative solution for gut health. The solution consists of a kit for the treatment and prevention of intestinal dysfunctions and inflammation,…
Adamas Biotech® has launched its first food supplement for individuals suffering from Irritable Bowel Syndrome associated with constipation (IBS-C) and, more generally, for the maintenance of intestinal function. The food supplement has been notified to the Ministry of Health and…
Theakine® IBS-C is the project for which Adamas Biotech® has been awarded a non-repayable grant of €425,700 from the National Biodiversity Future Center (NBFC), a research center coordinated by the National Research Council (CNR). Today, Adamas Biotech obtained official registration…
On 8 November 2024, Adamas Biotech® obtained official registration from the Italian Ministry of Health for Theakine® Prost, the first food supplement based on green tea catechins (Theaphenon E®) developed for prostate well-being and associated disorders. The supplement, marketed as…
The Startup Secures €425,700 in Funding Adamas Biotech® has received official confirmation of the grant award from the National Biodiversity Future Center (NBFC), Italy’s first national research and innovation center dedicated to biodiversity and coordinated by the National Research Council…
In collaboration with INBB and University of Parma, Adamas Biotech has published its preclinical research on green tea catechins' cardioprotective effects on the diabetic heart and their mechanism of action. The research revealed that increased expression and activity of SIRT1…
Forbes magazine, in its new editorial "Small Giants," has featured Cube Labs in its list of 100 Companies of Champions, highlighting the COVID-19 prophylactic technology codeveloped by Adamas Biotech and DTech, both Cube Labs companies. The DTech Biogel Spray with…